ATP7A defect

Here is a comprehensive overview of ATP7A defects, synthesized from multiple authoritative medical textbooks.

ATP7A Defect - Menkes Disease (and Allelic Variants)

Gene and Protein

ATP7A (Xq21.1) encodes a P-type ATPase copper transporter - a 1500-amino acid transmembrane protein located on the trans-Golgi membrane. Its roles are:
  1. Export dietary copper from enterocytes into the portal circulation
  2. Deliver intracellular copper to cuproenzymes within the Golgi apparatus
  3. Efflux of excess copper from most cells (except hepatocytes, which rely on the homologous ATP7B)
Loss-of-function mutations in ATP7A impair copper egress from intestinal epithelial cells, causing copper to accumulate in enterocytes while systemic tissues suffer profound copper deficiency. - Emery's Elements of Medical Genetics and Genomics, p. 294; Andrews' Diseases of the Skin, p. 4002

Allelic Spectrum

DisorderSeverityKey Features
Classic Menkes diseaseSevereNeurodegeneration, kinky hair, early death
Occipital Horn Syndrome (OHS)ModerateConnective tissue > neurological
ATP7A-related distal motor neuropathyMildAdult-onset, Charcot-Marie-Tooth-like

Classic Menkes Disease

Inheritance and Epidemiology

  • X-linked recessive - affects males almost exclusively
  • Prevalence: ~1 in 35,000 live male births (possibly as high as 1:8,664 by genome-based ascertainment)
  • Typically presents after a normal 6-12 week honeymoon period

Pathophysiology

Because ATP7A is absent or non-functional, copper cannot be exported from intestinal enterocytes. Most cuproenzymes are therefore deprived of their cofactor:
EnzymeNormal FunctionEffect of Deficiency
Cytochrome C oxidaseMitochondrial electron transportNeurodegeneration, energy failure
Lysyl oxidaseCross-linking collagen/elastinConnective tissue laxity, vascular fragility, kinky hair
Dopamine beta-hydroxylaseNorepinephrine synthesisAutonomic dysfunction
TyrosinaseMelanin synthesisDepigmented hair
Superoxide dismutaseFree radical defenseOxidative damage
CeruloplasminCopper/iron transportLow serum ceruloplasmin
Peptidylglycine alpha-amidating monooxygenase (PAM)Neuroendocrine peptide processingHormonal dysregulation
Lysyl oxidase requires copper to oxidatively deaminate lysyl residues, forming the cross-links essential for collagen and elastin integrity - this explains both the connective tissue findings and the twisted, brittle hair. - Harper's Illustrated Biochemistry 32e, p. 2888

Clinical Features

Prodrome (0-6 weeks): Normal birth and early development.
Early presentation (2-3 months):
  • Feeding difficulties, vomiting, poor weight gain
  • Seizures (often infantile spasms / hypsarrhythmia on EEG)
  • Hypothermia
Characteristic features:
  • Kinky/steely hair (pili torti + trichorrhexis nodosa + monilethrix) - ivory-white, wiry, sparse, twisted, brittle; resembles steel wool or copper-deficient sheep's wool
  • Facies: pudgy face, exaggerated "Cupid's bow" upper lip
  • Skin: pale, lax
Neurological:
  • Progressive hypotonia
  • Psychomotor regression / severe developmental delay
  • Uncontrollable seizures progressing to status epilepticus
  • Neuropathology: neovascularization of cerebral arteries, cystic medial degeneration, cerebellar hypoplasia, focal cortical dysplasias, profound Purkinje cell loss
Connective tissue:
  • Osteoporosis, joint laxity
  • Vascular anomalies (arterial tortuosity)
Ophthalmology: Ocular abnormalities
Prognosis: Death usually by 2-3 years from recurrent respiratory infections and neurological deterioration. - Bradley and Daroff's Neurology in Clinical Practice; Andrews' Diseases of the Skin
Infant with Menkes disease showing profound generalized hypotonia, flaccid posture, and sparse abnormal hair

Occipital Horn Syndrome (OHS)

A milder allelic variant - hypomorphic ATP7A mutations preserve some protein function. Predominantly a connective tissue disorder presenting in early-to-middle childhood:
  • Occipital horns (wedge-shaped bony exostoses at skull base - sites of trapezius/sternomastoid attachment)
  • Skin and joint laxity (cutis laxa phenotype)
  • Bladder diverticula, inguinal hernias
  • Minimal neurological involvement
  • Patients survive into adulthood
ATP7A mediates copper transport into the Golgi for lysyl oxidase activation - reduced activity preferentially impacts connective tissue cross-linking. - Fitzpatrick's Dermatology, p. 3510

ATP7A-Related Distal Motor Neuropathy

  • Adult-onset, progressive distal motor neuropathy resembling Charcot-Marie-Tooth disease
  • Pes cavus, distal muscle wasting
  • No copper/ceruloplasmin abnormalities
  • Caused by missense mutations preserving partial copper transport

Genetics and Mutation Spectrum

  • Gene locus: Xq21.1 (X-linked, so affected females are very rare - reported with X-autosome translocations disrupting the gene)
  • ~15-20% large deletions (usually classic severe phenotype)
  • Point mutations: 23% splice-site, 21% nonsense, 17% missense, 39% small deletions/insertions
  • Variable expressivity even with identical mutations within a family

Diagnosis

TestFinding
Serum copperVery low
Serum ceruloplasminVery low
Catechol ratio (DOPA/DHPG)High DOPA, dopamine, DOPAC; low DHPG - reflects dopamine beta-hydroxylase deficiency
Hair microscopyPili torti, trichorrhexis nodosa, monilethrix
Skin fibroblast copper egress studiesAbnormal
Molecular: ATP7A gene sequencingConfirms mutation
The catechol metabolite ratio (reflecting impaired dopamine-beta-hydroxylase) is a sensitive early biomarker for neonatal diagnosis. - Andrews' Diseases of the Skin, p. 4002

Treatment

  • Copper-histidine (subcutaneous or IV): Partially bypasses the intestinal block. Restores serum copper and ceruloplasmin. Best results when started before neurological deterioration (neonatal period). - Bradley and Daroff's Neurology
  • Pamidronate: Improves bone mineral density
  • Gene therapy / antisense oligonucleotides: Experimental (promising results in zebrafish models and early human trials with viral-mediated ATP7A gene therapy)
  • L-threo-DOPS (L-threo-dihydroxyphenylserine): Corrects neurochemical abnormalities in mouse models

Comparison with Wilson Disease (ATP7B)

FeatureMenkes (ATP7A)Wilson (ATP7B)
GeneATP7A (Xq21.1)ATP7B (13q14)
InheritanceX-linked recessiveAutosomal recessive
Primary organIntestine (efflux)Liver (biliary excretion)
Copper resultSystemic deficiencySystemic accumulation
OnsetInfancyChildhood/young adult
Serum copper/ceruloplasminLowLow (despite accumulation)
TreatmentCopper supplementationChelation (D-penicillamine, trientine)

Sources: - Emery's Elements of Medical Genetics and Genomics, p. 294 | - Harper's Illustrated Biochemistry 32e, p. 2888 | - Bradley and Daroff's Neurology in Clinical Practice | - Andrews' Diseases of the Skin, p. 4002-4004 | - Fitzpatrick's Dermatology, p. 3510 | - Dermatology 2-Volume Set 5e | - GeneReviews: ATP7A-Related Copper Transport Disorders
This is a shared conversation. Sign in to Orris to start your own chat.